New app seeks to improve overall health of hearing aid users

A company that specializes in hearing loss is looking to help its hearing aid users improve their overall health with a new mobile application.

Oticon recently launched its new HearingFitness app, which is designed to help hearing aid users understand how their listening environments and health habits impact their hearing and overall health.

“By engaging and encouraging users to be active partners in their healthcare, HearingFitness enables a more personalized hearing care. With informed decisions, users will be able to optimize their hearing aids to their specific, individual and changing needs and sound environments,” a press release stated. “It is the start of data-driven hearing care and yet another example of Oticon’s ability to revolutionize the way modern technology can benefit hearing aid users.”

According to the release, the app works with Oticon’s internet-connected hearing aids. It monitors and analyzes a user’s hearing aid use, listening environments and habits, and makes recommendations to help wearers optimize the use of their hearing aids.

The app allows people to set daily hearing goals and track their progress. It also notes quality listening environments and sends reminders to wear hearing aids in tough hearing environments.

“User data analysis to improve customer experiences is used the world over. Oticon will utilize this tried and proven method in order to gather the most authentic information to develop the hearing aid technologies of tomorrow,” the release stated. “By combining real-time hearing aid data with lifestyle and healthcare big data analytics, HearingFitness will evolve and improve a user’s hearing solution according to their personal habits.”

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.